The first two days of this week featured a consolidation trade after some strong or frothy trading the prior few weeks in the wake of the Trump electoral victory. Some might say a correction is overdue; in my case, particularly, I was struck by the recent nomination of new FTC Commissioners. Ticker Target is not…
GTLB
This morning we made some changes in our high growth portfolio, selling the balance of the Shift 4 position and adding to positions in Datadog, SentinelOne, Unity and GitLab. The details are as follows: We sold 500 shares of Shift4 at 104.29. This eliminated the position and raised $52,140. To reiterate, our sale was related to the appointment…
a) Zscaler: The business is growing but one metric is misleading investors As I write this Tuesday evening, Zscaler shares are down 15% to around $164. That puts the year to date loss of the shares to around 13%. I point that out simply because the question to consider is whether or not the company is…
This morning Reuters published an article in which it suggests that GitLab has hired investment bankers and has seen interest from a variety of potential purchasers including Google and Amazon. Rumors about a GitLab sale have been circulating from time to time. The founder and CEO of GitLab, Sid Sijbrandij has been battling cancer and announced that his…
Sales of 1500 shares of UiPath and Sale of 150 shares of Dynatrace: Purchase of 300 shares of Nutanix, Purchase of 200 shares of GitLab As we had indicated, we have now eliminated UiPath from the portfolio. Its latest earnings report and guidance were very disappointing, and while the narrative may play out, we simply…
The divergence between Crowdstrike and Zscaler (and most everything else). The misunderstood quarter of GitLab; Pagaya raises EBITDA guidance-hopefully construed positively. 1. Crowdstrike Pattern recognition is supposed to be the mainstay of analysis. Most of the time, when I attempt to write an article about a company, or an event, I try to compare it…
Panics, like bubbles come and go. We are currently experiencing a bit of a panic, although a 2 day + pullback of around 8+% is only borderline panic. The causes are well known. The greatest cause is geo political angst…the potential of a general outbreak of war in the Middle East as various state actors…
Sale of 300 shares of Procore (entire position); purchase of 100 shares of Shift4, 200 shares of Sentinel One; 100 shares of GitLab; 100 shares of Affirm; 100 Shares of UiPath We made some portfolio changes in the high growth portfolio today. We decided to eliminate the last of the Procore position, selling 300 shares while adding…
Summary GitLab shares stumbled in the wake of very conservative guidance for the current fiscal year. The guidance belied very favorable trends in the sales environment including a quarter of record bookings and several other significant sales milestones. The company’s growth in margins and in free cash flow generation has been impressive. The company’s AI…
Sold 200 shares of Procore and bought 400 shares of GitLab Earlier today we made a change in the Ticker Target High Growth portfolio. We sold 200 shares of Procore, reducing our position to 300 shares and a weighting of 2.5%. We sold the Procore shares at a price of $81.89 and the net proceeds were…